Elanor secures ASX waiver extending deadline for Firmus Capital acquisition securities issuance

ASX Waiver Eases Pressure on Firmus Acquisition Timeline

Elanor Investors Group (ASX:ENN) has secured a crucial waiver from ASX Limited that extends the deadline for issuing stapled securities as consideration for acquiring Singapore-based real estate investment manager Firmus Capital. Originally set to issue by 10 May 2026, Elanor now has until 10 July 2026 to complete the securities issuance, thanks to the waiver of Listing Rule 14.7. This extension comes amid delays in obtaining necessary regulatory approvals outside Elanor's control, which have held up completion of the acquisition.

Regulatory Approvals and Waiver Conditions

The waiver specifically relaxes the requirement that Elanor must issue the securities within one month post-securityholder meeting, allowing up to two additional months beyond the initial extension granted in September 2025. The Consideration Securities are to be issued to Su Kiat Lim or his nominated entity Laville Pte. Ltd. under the terms detailed in Elanor's extraordinary general meeting notice from January 2026. ASX's conditions include timely market updates explaining the delay and adherence to the original terms agreed with securityholders.

Strategic Importance of the Firmus Acquisition

The Firmus deal is a cornerstone of Elanor's broader strategy to expand its footprint in Asia, particularly in Singapore's retail and office real estate sectors where Firmus manages approximately S$658 million in assets. This acquisition follows Elanor's recent $125 million recapitalisation with Rockworth Capital Partners, which has helped stabilise its balance sheet and set the stage for growth across the region. The acquisition's completion is pivotal to unlocking strategic and financial benefits for Elanor's securityholders, who have weathered recent earnings losses and asset divestments during the group's restructuring phase.

Elanor's recapitalisation and acquisition progress have been closely tracked, with the group reporting a half-year loss amid asset sales and ongoing recapitalisation efforts. The waiver and extended timeline provide breathing room to finalise the Firmus transaction without jeopardising the broader recapitalisation outcomes or shareholder value, as highlighted in recent updates on the group's financial and strategic repositioning $125M recapitalisation with Rockworth and HY26 loss amid recapitalisation progress.

Implications for Securityholders and Market Transparency

While the waiver alleviates immediate regulatory hurdles, it also raises questions about the timing and certainty of the Firmus acquisition's completion. Elanor is obligated to keep the market informed about the reasons for any further delays, maintaining transparency with investors. The strategic rationale for the acquisition remains intact, but the extended timeline underscores the challenges of cross-border real estate transactions subject to regulatory scrutiny.